Platform Therapeutic Education in Heart Failure and Coronary Disease

NCT01869452 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 555

Last updated 2015-05-05

No results posted yet for this study

Summary

A first therapeutic education is given before patient's discharge at the hospital, then a dedicated nurse follows patients through the phone,regularly according to patients' needs, continues to give advise on risk factors, information on medication and alert symptoms and therapeutic education.

Conditions

  • Heart Failure
  • Acute Coronary Syndrome
  • Coronary Bypass Graft Stenosis of Native Artery Graft

Interventions

BEHAVIORAL

therapeutic education

knowledge of disease, risk factors, diet, medication, alert symptoms

Sponsors & Collaborators

  • union nationale de formation et d'evaluation en medecine cardio-vasculaire

    collaborator UNKNOWN
  • Resicard

    lead OTHER

Principal Investigators

  • ariel a cohen, md · Resicard

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2013-06-30
Completion
2014-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01869452 on ClinicalTrials.gov